Do urinary mast cell mediators predict immune response to BCG in patients with primary high-grade non-muscle invasive bladder cancer?

Simsekoglu, Muhammed; Kaleler, Islim; ÖNAL, Bülent; Demirdag, Çetin; ÇİTGEZ, Sinharib; Uslu, Ezel; Erozenci, Ahmet; Talat, Zubeyr

doi:10.1111/ijcp.13959

Do urinary mast cell mediators predict immune response to BCG in patients with primary high-grade non-muscle invasive bladder cancer?

Atıf İçin Kopyala

Simsekoglu M. F. , Kaleler I., ÖNAL B. , Demirdag Ç. , ÇİTGEZ S. , Uslu E., ...Daha Fazla

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021 (SCI İndekslerine Giren Dergi)

Cilt numarası:
Basım Tarihi: 2021
Doi Numarası: 10.1111/ijcp.13959
Dergi Adı: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Özet

Background Mast cells play a critical role in cancer-associated immunity. We aimed to determine the predictive value of urinary mast cell mediators in patients with non-muscle invasive bladder cancer (NMIBC) treated with Bacillus Calmette-Guerin (BCG) immunotherapy.